Literature DB >> 29464327

Unclassified sclerosing malignant melanomas with AKAP9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumors.

Emilie Perron1,2,3, Daniel Pissaloux4, Angela Neub5, Daniel Hohl5, Marie Dominique Tartar6, Laurent Mortier7, Laurent Alberti4, Arnaud de la Fouchardiere4.   

Abstract

The current classification of melanocytic tumors includes clinical, pathological, and molecular data. A subset of lesions remains difficult to classify according to these complex multilayer schemes. We report two cases of deeply infiltrating melanomas with a sclerosing background. The first case occurred on the back of a middle-aged man appearing clinically as a dermatofibroma. The architectural and cytological aspects resembled those of a desmoplastic melanoma but the strong expression of both melanA and HMB45, two stainings usually reported as negative in this entity, raised the question of an alternate diagnosis. The second case was a large, slowly growing, perivulvar tumor in a middle-aged woman. The morphology was complex with a central junctional spitzoid pattern associating an epidermal hyperplasia with large nests of large spindled melanocytes. The dermal component was made of deeply invasive strands and nests of nevoid unpigmented melanocytes surrounded by fibrosis; a perineural invasion was present at the periphery of the lesion. In both cases, aCGH found, among many other anomalies, a chromosomal breakpoint at the BRAF locus. RNA sequencing identified in both an AKAP9-BRAF gene fusion. A complementary resection was performed and no relapses have been observed in the respectively 15 and 6 months of follow-up. Both of these melanomas remained unclassified. We further review the variety of melanocytic tumors associated with such BRAF fusions.

Entities:  

Keywords:  BRAF fusion; Desmoplastic stromal reaction; Melanocytic tumors; Melanoma

Mesh:

Substances:

Year:  2018        PMID: 29464327     DOI: 10.1007/s00428-017-2290-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.

Authors:  Barbara Dessars; Linda E De Raeve; Hakim El Housni; Catherine J Debouck; Pierre J Sidon; Renato Morandini; Diane Roseeuw; Ghanem E Ghanem; Gilbert Vassart; Pierre Heimann
Journal:  J Invest Dermatol       Date:  2007-02-15       Impact factor: 8.551

2.  A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.

Authors:  Sapna M Amin; Alexandra M Haugh; Christina Y Lee; Bin Zhang; Jeffrey A Bubley; Emily A Merkel; Anna Elisa Verzì; Pedram Gerami
Journal:  Am J Surg Pathol       Date:  2017-04       Impact factor: 6.394

3.  Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion.

Authors:  Alexander M Menzies; Iwei Yeh; Thomas Botton; Boris C Bastian; Richard A Scolyer; Georgina V Long
Journal:  Pigment Cell Melanoma Res       Date:  2015-07-03       Impact factor: 4.693

4.  Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical study of 28 cases.

Authors:  Paul A Kay; A Daniel Pinheiro; Christine M Lohse; V Shane Pankratz; Kerry D Olsen; Jean E Lewis; Antonio G Nascimento
Journal:  Int J Surg Pathol       Date:  2004-01       Impact factor: 1.271

5.  Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.

Authors:  Thomas Botton; Iwei Yeh; Tyrrell Nelson; Swapna S Vemula; Alyssa Sparatta; Maria C Garrido; Maryline Allegra; Stephane Rocchi; Philippe Bahadoran; Timothy H McCalmont; Philip E LeBoit; Elizabeth A Burton; Gideon Bollag; Robert Ballotti; Boris C Bastian
Journal:  Pigment Cell Melanoma Res       Date:  2013-08-19       Impact factor: 4.693

6.  Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

Authors:  J A Carlson; G R Dickersin; A J Sober; R L Barnhill
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

Review 7.  Desmoplastic melanoma: a review.

Authors:  Lucy L Chen; Natalia Jaimes; Christopher A Barker; Klaus J Busam; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2012-12-23       Impact factor: 11.527

8.  TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms.

Authors:  Seungjae Lee; Raymond L Barnhill; Reinhard Dummer; James Dalton; Jianrong Wu; Alberto Pappo; Armita Bahrami
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

9.  The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.

Authors:  Jeffrey S Ross; Kai Wang; Juliann Chmielecki; Laurie Gay; Adrienne Johnson; Jacob Chudnovsky; Roman Yelensky; Doron Lipson; Siraj M Ali; Julia A Elvin; Jo-Anne Vergilio; Steven Roels; Vincent A Miller; Brooke N Nakamura; Adam Gray; Michael K Wong; Philip J Stephens
Journal:  Int J Cancer       Date:  2015-09-08       Impact factor: 7.396

10.  Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.

Authors:  A Hunter Shain; Maria Garrido; Thomas Botton; Eric Talevich; Iwei Yeh; J Zachary Sanborn; Jongsuk Chung; Nicholas J Wang; Hojabr Kakavand; Graham J Mann; John F Thompson; Thomas Wiesner; Ritu Roy; Adam B Olshen; Alexander Gagnon; Joe W Gray; Nam Huh; Joe S Hur; Klaus J Busam; Richard A Scolyer; Raymond J Cho; Rajmohan Murali; Boris C Bastian
Journal:  Nat Genet       Date:  2015-09-07       Impact factor: 38.330

View more
  1 in total

Review 1.  The Morpho-Molecular Landscape of Spitz Neoplasms.

Authors:  Carlo Alberto Dal Pozzo; Rocco Cappellesso
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.